6 completed. 6 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 6 |
| Phase 3 | 1 | Completed 1 |
Follow Arrhythmia: new trials by email Literature Review of Arrhythmia trials Research Report on Arrhythmia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Multi-centre Study Comparing the Effects of AZD2927 and Placebo on the Electrical Activity in the Heart in Patients AZD2927, Placebo - Arrhythmia | Phase 2 | Completed | AstraZeneca | 20 | 2011-09-01 | 2012-11-27 |
| Effects of Docosahexaenoic Acid (DHA) on Heart Rate Variability in Elderly Patients Docosahexaenoic acid (DHA), Placebo - Arrhythmia | Phase 2 / Phase 3 | Completed | Campus Bio-Medico University | 50 | 2008-06-01 | 2009-11-25 |
| Defining The Role Of Dialysate Magnesium In Arrhythmogenicity On Dialysis Dialysate Magnesium (Concentration) - Chronic Kidney Disease, Arrhythmia | Phase 2 | Completed | University of Michigan | 25 | 2005-11-01 | 2014-12-09 |
| Double Blind Placebo Controlled Dose Ranging Study of the Efficacy and Safety of SSR149744c 100 or 300 mg for the Prevention of ventrICular ARrhythmia-triggered Icd interventiOnS SSR149744C - Arrhythmia, Tachycardia, Ventricular | Phase 2 | Completed | Sanofi | 153 | 2005-06-01 | 2012-05-08 |
| Antiarrhythmic Effects of N-3 Fatty Acids dietary n-3 polyunsaturated fatty acids - Arrhythmia, Heart Diseases | Phase 2 | Completed | National Heart, Lung, and Blood Institute (NHLBI) | 1999-02-01 | 2016-02-18 | |
| Cardiac Arrhythmia Pilot Study (CAPS) encainide, moricizine, flecainide - Arrhythmia, Cardiovascular Diseases | Phase 2 | Completed | National Heart, Lung, and Blood Institute (NHLBI) | 1982-09-01 | 2012-04-27 |
Arrhythmias, Cardiac (6) · Heart Diseases (2) · Tachycardia, Ventricular (2) · Ventricular Fibrillation (2) · Cardiovascular Diseases (1) · Death, Sudden, Cardiac (1) · Renal Insufficiency, Chronic (1)
Pathologic Processes (6) · Pathological Conditions, Signs and Symptoms (6) · Cardiovascular Diseases (5) · Heart Diseases (4) · Cardiac Conduction System Disease (2) · Tachycardia (2) · Chronic Disease (1) · Death (1) · Death, Sudden (1) · Disease Attributes (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Heart Arrest (1) · Kidney Diseases (1) · Male Urogenital Diseases (1)
AZD2927 (1) · Docosahexaenoic Acids (1) · Encainide (1) · Flecainide (1) · Imipramine (1) · Moricizine (1) · celivarone (1)
National Heart, Lung, and Blood Institute (NHLBI) (2) · AstraZeneca (1) · Campus Bio-Medico University (1) · Sanofi (1) · University of Michigan (1)
Italy (2) · United States (2) · Belgium (1) · Canada (1) · Czechia (1) · Germany (1) · Netherlands (1) · Norway (1) · Sweden (1) · Switzerland (1)
Allan Barker (1) · Craig Pratt (1) · David Richardson (1) · Francesco M Serino, MD (1) · Giuseppe Rosano, MD (1) · Hakan Walfridsson, MD, PHD (1) · Israel Stein (1) · J. Bigger (1) · Lawrence Griffith (1) · Marco Miceli, MD (1) · Michael Sather (1) · Panduranga S Rao, MD, DNB, MS (1) · Pierre Theroux (1) · Raffaele Antonelli Incalzi, MD (1)
R01HL061682 (1)